Navigation Links
Steve Andrzejewski Joins Nycomed US Inc.

MELVILLE, N.Y., July 19 /PRNewswire/ -- Nycomed US Inc. today announced the appointment of Steve Andrzejewski as the new Chief Executive Officer. He assumes immediate responsibility for Nycomed US Inc., including manufacturing in Melville and Hicksville, New York, distribution and commercial operations for the three marketing and sales divisions Fougera, PharmaDerm and Savage Laboratories.

Steve Andrzejewski has been working in the pharmaceutical and healthcare industry for more than 20 years. He joins us from King Pharmaceuticals where he served as Corporate Head, Commercial Operations first and then as Chief Commercial Officer.

He holds a Bachelor's degree in Psychology from Hamilton College in New York, and an MBA in Finance/International Business from New York University. Steve Andrzejewski began his career as a sales representative at Schering-Plough Corporation, and rose steadily through the ranks over the next 16 years. From 1998 on he held a number of Vice President positions at Schering-Plough, including Marketing and New Products. Before joining King Pharmaceuticals, he was the Senior Vice President of the Commercial Business at Endo Pharmaceuticals.

"I am delighted to welcome Steve Andrzejewski as our new Chief Executive Officer for Nycomed's US business," says Hakan Bjorklund, Chief Executive Officer of Nycomed. "His experience with both generics and proprietary products will be great assets to guide Nycomed US through the challenging and changing business environment."

About Nycomed US Inc.

Nycomed US Inc. is a subsidiary of Nycomed and operates three divisions in the United States focused on specialty pharmaceuticals in dermatology. Founded in 1849, Fougera is a division of Nycomed US Inc. and is the leading manufacturer and distributor of a wide range of topical products.  The PharmaDerm division is dedicated to developing and commercializing novel prescription products to treat diseases and conditions of the skin -- the largest organ of the human body.  Nycomed US Inc. also markets and sells Savage Laboratories products, which focus on emergency care.  For more information on Fougera's complete line of products, please call Fougera Customer Service at (800) 645-9833 or visit the company online at  Information on PharmaDerm products can be found online at

More information is available at

SOURCE Nycomed US Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
2. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
3. D-M-S Holdings, Inc. Announces the Filing of a Lawsuit Against Veridian Healthcare, LLC, Steven M. Bisulca and Michael Mazza
4. Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowleys American Scene Radio Program and Featured on Money Channel Inc.
5. Beverly Hills Eye Surgeon Gets Surprise Inundation of Requests From Around the World for Information About New Treatment That Saved USA Bobsled Captain Steve Holcombs Eyesight
6. Vanda Pharmaceuticals Adds Former U.S. Surgeon General, Steven Galson, to its Board of Directors
7. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
8. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
9. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
10. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
11. MedicAlert Foundation Joins The Alzheimers Association to Offer MedicAlert(R) + Alzheimers Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... Global Cell Surface Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... of Toronto and the University of British Columbia suggested that laws requiring bicyclists to ... article explains that part of the reason for the controversial conclusion is that, while ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has ... it. Surviving Mesothelioma has just posted the findings on the website. Click here ... the cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... Lizzie’s ... , The company is offering customers 10% off of their purchase of lice treatment ... treatment at full price. According to a company spokesperson. “Finding lice is a sure ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in ... (see Table 1-1 ). More than 3.7 billion people under the age of ... 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection . , "The ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... A simply ... Jones, is an interesting show that delves into an array of issues that are ... that could benefit from open dialogue, this show is changing the subjects consumers focus ...
Breaking Medicine News(10 mins):